Collectively, these studies demonstrate that SIRT6 acts as a protective regulator in both peripheral adipose tissue and central hypothalamic microglia, highlighting its potential as a therapeutic target for obesity and obesity-related metabolic dysfunction. This evidence concerns the gene SIRT6 and obesity disorder.